MYX mayne pharma group limited

Ann: 2022 Full Year Media Release, page-4

  1. 4,489 Posts.
    lightbulb Created with Sketch. 3234
    I think there’s a typo. Pretty sure it should read:

    Mayne Pharma’s Chair Mr Frank Condella said, “We are extremely pleased to have announced the sale of Metrics to Catalent which is a key part of the Board’s transformation agenda to reposition Mayne Pharma for growth acquisition...”

    But that too is probably a year or more off now as well rolleyes.png
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.95
Change
-0.080(1.59%)
Mkt cap ! $401.3M
Open High Low Value Volume
$5.03 $5.03 $4.91 $565.7K 114.5K

Buyers (Bids)

No. Vol. Price($)
6 1720 $4.93
 

Sellers (Offers)

Price($) Vol. No.
$4.95 2149 5
View Market Depth
Last trade - 11.57am 23/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.